Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas-ligand pathway in mice

Abdelali Agouni, Pierre-Henri Ducluzeau, Tarek Benameur, Sebastien Faure, Martina Sladkova, Lucie Duluc, Georges Leftheriotis, Olga Pechanova, Mirela Delibegovic, Maria Carmen Martinez, Ramaroson Andriantsitohaina

Research output: Contribution to journalArticle

36 Citations (Scopus)
5 Downloads (Pure)

Abstract

Microparticles are membrane vesicles with pro-inflammatory properties. Circulating levels of microparticles have previously been found to be elevated in patients with metabolic syndrome (MetS). The present study aimed to evaluate the effects of in vivo treatment with microparticles, from patients with MetS and from healthy subjects (HS), on ex vivo vascular function in mice. Microparticles isolated from MetS patients or HS, or a vehicle were intravenously injected into mice, following which vascular reactivity in response to vasoconstrictor agonists was assessed by myography with respect to cyclo-oxygenase pathway, oxidative and nitrosative stress. Injection of microparticles from MetS patients into mice induced vascular hypo-reactivity in response to serotonin. Hypo-reactivity was associated with up-regulation of inducible NO-synthase and increased production of NO, and was reversed by the NO-synthase inhibitor (N(G)-nitro-L-arginine). The selective COX-2 inhibitor (NS398) reduced the contractile effect of serotonin in aortas from mice treated with vehicle or HS microparticles; however, this was not observed within mice treated with MetS microparticles, probably due to the ability of MetS microparticles to enhance prostacyclin. MetS microparticle-mediated vascular dysfunction was associated with increased reactive oxygen species (ROS) and enhanced expression of the NADPH oxidase subunits. Neutralization of the pro-inflammatory pathway Fas/FasL completely prevented vascular hypo-reactivity and the ability of MetS microparticles to enhance both inducible NO-synthase and monocyte chemoattractant protein-1 (MCP-1). Our data provide evidence that microparticles from MetS patients induce ex vivo vascular dysfunction by increasing both ROS and NO release and by altering cyclo-oxygenase metabolites and MCP-1 through the Fas/FasL pathway.

Original languageEnglish
Article numbere27809
Number of pages11
JournalPloS ONE
Volume6
Issue number11
Early online date15 Nov 2011
DOIs
Publication statusPublished - 15 Nov 2011

Fingerprint

Fas Ligand Protein
metabolic syndrome
blood vessels
Nitric Oxide Synthase
Blood Vessels
Chemokine CCL2
Prostaglandin-Endoperoxide Synthases
Reactive Oxygen Species
Serotonin
mice
Cyclooxygenase 2 Inhibitors
NADPH Oxidase
Vasoconstrictor Agents
Epoprostenol
prostaglandin synthase
Metabolites
Arginine
Healthy Volunteers
Membranes
serotonin

Cite this

Agouni, A., Ducluzeau, P-H., Benameur, T., Faure, S., Sladkova, M., Duluc, L., ... Andriantsitohaina, R. (2011). Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas-ligand pathway in mice. PloS ONE, 6(11), [e27809]. https://doi.org/10.1371/journal.pone.0027809

Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas-ligand pathway in mice. / Agouni, Abdelali; Ducluzeau, Pierre-Henri; Benameur, Tarek; Faure, Sebastien; Sladkova, Martina; Duluc, Lucie; Leftheriotis, Georges; Pechanova, Olga; Delibegovic, Mirela; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson.

In: PloS ONE, Vol. 6, No. 11, e27809, 15.11.2011.

Research output: Contribution to journalArticle

Agouni, A, Ducluzeau, P-H, Benameur, T, Faure, S, Sladkova, M, Duluc, L, Leftheriotis, G, Pechanova, O, Delibegovic, M, Martinez, MC & Andriantsitohaina, R 2011, 'Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas-ligand pathway in mice', PloS ONE, vol. 6, no. 11, e27809. https://doi.org/10.1371/journal.pone.0027809
Agouni, Abdelali ; Ducluzeau, Pierre-Henri ; Benameur, Tarek ; Faure, Sebastien ; Sladkova, Martina ; Duluc, Lucie ; Leftheriotis, Georges ; Pechanova, Olga ; Delibegovic, Mirela ; Martinez, Maria Carmen ; Andriantsitohaina, Ramaroson. / Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas-ligand pathway in mice. In: PloS ONE. 2011 ; Vol. 6, No. 11.
@article{97c76a8f1b774ecb840b3d7e6972f2b4,
title = "Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas-ligand pathway in mice",
abstract = "Microparticles are membrane vesicles with pro-inflammatory properties. Circulating levels of microparticles have previously been found to be elevated in patients with metabolic syndrome (MetS). The present study aimed to evaluate the effects of in vivo treatment with microparticles, from patients with MetS and from healthy subjects (HS), on ex vivo vascular function in mice. Microparticles isolated from MetS patients or HS, or a vehicle were intravenously injected into mice, following which vascular reactivity in response to vasoconstrictor agonists was assessed by myography with respect to cyclo-oxygenase pathway, oxidative and nitrosative stress. Injection of microparticles from MetS patients into mice induced vascular hypo-reactivity in response to serotonin. Hypo-reactivity was associated with up-regulation of inducible NO-synthase and increased production of NO, and was reversed by the NO-synthase inhibitor (N(G)-nitro-L-arginine). The selective COX-2 inhibitor (NS398) reduced the contractile effect of serotonin in aortas from mice treated with vehicle or HS microparticles; however, this was not observed within mice treated with MetS microparticles, probably due to the ability of MetS microparticles to enhance prostacyclin. MetS microparticle-mediated vascular dysfunction was associated with increased reactive oxygen species (ROS) and enhanced expression of the NADPH oxidase subunits. Neutralization of the pro-inflammatory pathway Fas/FasL completely prevented vascular hypo-reactivity and the ability of MetS microparticles to enhance both inducible NO-synthase and monocyte chemoattractant protein-1 (MCP-1). Our data provide evidence that microparticles from MetS patients induce ex vivo vascular dysfunction by increasing both ROS and NO release and by altering cyclo-oxygenase metabolites and MCP-1 through the Fas/FasL pathway.",
author = "Abdelali Agouni and Pierre-Henri Ducluzeau and Tarek Benameur and Sebastien Faure and Martina Sladkova and Lucie Duluc and Georges Leftheriotis and Olga Pechanova and Mirela Delibegovic and Martinez, {Maria Carmen} and Ramaroson Andriantsitohaina",
year = "2011",
month = "11",
day = "15",
doi = "10.1371/journal.pone.0027809",
language = "English",
volume = "6",
journal = "PloS ONE",
issn = "1932-6203",
publisher = "PUBLIC LIBRARY SCIENCE",
number = "11",

}

TY - JOUR

T1 - Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas-ligand pathway in mice

AU - Agouni, Abdelali

AU - Ducluzeau, Pierre-Henri

AU - Benameur, Tarek

AU - Faure, Sebastien

AU - Sladkova, Martina

AU - Duluc, Lucie

AU - Leftheriotis, Georges

AU - Pechanova, Olga

AU - Delibegovic, Mirela

AU - Martinez, Maria Carmen

AU - Andriantsitohaina, Ramaroson

PY - 2011/11/15

Y1 - 2011/11/15

N2 - Microparticles are membrane vesicles with pro-inflammatory properties. Circulating levels of microparticles have previously been found to be elevated in patients with metabolic syndrome (MetS). The present study aimed to evaluate the effects of in vivo treatment with microparticles, from patients with MetS and from healthy subjects (HS), on ex vivo vascular function in mice. Microparticles isolated from MetS patients or HS, or a vehicle were intravenously injected into mice, following which vascular reactivity in response to vasoconstrictor agonists was assessed by myography with respect to cyclo-oxygenase pathway, oxidative and nitrosative stress. Injection of microparticles from MetS patients into mice induced vascular hypo-reactivity in response to serotonin. Hypo-reactivity was associated with up-regulation of inducible NO-synthase and increased production of NO, and was reversed by the NO-synthase inhibitor (N(G)-nitro-L-arginine). The selective COX-2 inhibitor (NS398) reduced the contractile effect of serotonin in aortas from mice treated with vehicle or HS microparticles; however, this was not observed within mice treated with MetS microparticles, probably due to the ability of MetS microparticles to enhance prostacyclin. MetS microparticle-mediated vascular dysfunction was associated with increased reactive oxygen species (ROS) and enhanced expression of the NADPH oxidase subunits. Neutralization of the pro-inflammatory pathway Fas/FasL completely prevented vascular hypo-reactivity and the ability of MetS microparticles to enhance both inducible NO-synthase and monocyte chemoattractant protein-1 (MCP-1). Our data provide evidence that microparticles from MetS patients induce ex vivo vascular dysfunction by increasing both ROS and NO release and by altering cyclo-oxygenase metabolites and MCP-1 through the Fas/FasL pathway.

AB - Microparticles are membrane vesicles with pro-inflammatory properties. Circulating levels of microparticles have previously been found to be elevated in patients with metabolic syndrome (MetS). The present study aimed to evaluate the effects of in vivo treatment with microparticles, from patients with MetS and from healthy subjects (HS), on ex vivo vascular function in mice. Microparticles isolated from MetS patients or HS, or a vehicle were intravenously injected into mice, following which vascular reactivity in response to vasoconstrictor agonists was assessed by myography with respect to cyclo-oxygenase pathway, oxidative and nitrosative stress. Injection of microparticles from MetS patients into mice induced vascular hypo-reactivity in response to serotonin. Hypo-reactivity was associated with up-regulation of inducible NO-synthase and increased production of NO, and was reversed by the NO-synthase inhibitor (N(G)-nitro-L-arginine). The selective COX-2 inhibitor (NS398) reduced the contractile effect of serotonin in aortas from mice treated with vehicle or HS microparticles; however, this was not observed within mice treated with MetS microparticles, probably due to the ability of MetS microparticles to enhance prostacyclin. MetS microparticle-mediated vascular dysfunction was associated with increased reactive oxygen species (ROS) and enhanced expression of the NADPH oxidase subunits. Neutralization of the pro-inflammatory pathway Fas/FasL completely prevented vascular hypo-reactivity and the ability of MetS microparticles to enhance both inducible NO-synthase and monocyte chemoattractant protein-1 (MCP-1). Our data provide evidence that microparticles from MetS patients induce ex vivo vascular dysfunction by increasing both ROS and NO release and by altering cyclo-oxygenase metabolites and MCP-1 through the Fas/FasL pathway.

U2 - 10.1371/journal.pone.0027809

DO - 10.1371/journal.pone.0027809

M3 - Article

VL - 6

JO - PloS ONE

JF - PloS ONE

SN - 1932-6203

IS - 11

M1 - e27809

ER -